Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Eur Radiol. 2019 Apr 1;29(10):5367–5377. doi: 10.1007/s00330-019-06168-x

Table 4:

MPM assigned categories breakdown of nodule risk prediction. Refer to Supplemental Table A.2 for complete size-based breakdown.

MPM Nodule Size Malignancy probability and associated clinical guidelines for treatment/ nodule evaluation
MC < 3% Watchful waiting 3–68% Needle biopsy > 68% Surgery
All 0M: 6B 61M: 225B 19M: 6B
0% malignant wait 98% benign immediate work-up
≥ 8mm to < 15mm 0M: 0B 26M: 91B 1M: 1B
0% malignant wait 100% benign immediate work-up
≥ 15mm 0M: 0B 24M: 24B 18M: 6B
0% malignant wait 100% benign immediate work-up
VA < 20% Watchful waiting 20–69% Needle biopsy > 69%Surgery
All 7M: 58B 51M: 163B 22M: 16B
9% malignant wait 76% benign immediate work-up
≥ 8mm to < 15mm 1M: 13B 25M: 75B 1M: 4B
4% malignant wait 86% benign immediate work-up
≥ 15mm 3M: 0B 18M: 18B 21M: 12B
7% malignant waits 100% benign immediate work-up
BU < 10% Low risk ≥ 10% Higher Risk
All 20M: 177B 60M: 60B
25% malignant wait 25% benign extra procedures
≥ 8mm to < 15mm 9M: 61B 18M: 31B
33% malignant wait 34% benign immediate work-up
≥ 15mm 0M: 1B 42M: 29B
0% malignant wait 97% benign immediate work-up
PU < 46.3%
Nodule considered benign
≥ 46.3%
Nodule considered malignant
All 8M: 87B 72M: 150B
10% malignant wait 63% benign immediate work-up
≥ 8mm to < 15mm 3M: 33B 24M: 59B
7% malignant wait 64% benign immediate work-up
> 15mm 3M: 4B 39M: 26B
7% malignant wait 87% benign immediate work-up

Definition of abbreviations: MPM – mathematical prediction model; MC – Mayo Clinic; VA – Veteran’s Affairs; BU – Brock University; PU – Peking University; M – malignant; B - benign